Treatment strategies for invasive fungal infections in patients with hematologic malignancies

被引：0
|
作者：
Wemeau, Mathieu [1 ]
机构：
[1] Ctr Hosp Reg & Univ Lille, Hopital Huriez, Serv Malad Sang, Lille, France
来源：
HEMATOLOGIE | 2011年 / 17卷 / 04期
关键词：
invasive fungal infections; antifungal prophylaxis; empirical antifungal therapy; preemptive antifungal therapy; hematologic malignancies;
D O I：
10.1684/hma.2011.0633
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Different strategies of treatment for invasive fungal infections (IFI) have been discussed on april 2011 during the annual congress of the EBMT. A prophylactic treatment is indicated for patients receiving an intensive chemotherapy for acute leukemia or a hematopoietic stem cell allograft. Posaconazole, with its particular pharmacokinetic properties and large spectrum, is validated in this indication. The preemptive strategy for the treatment of IFI, based on early diagnosis elements, has not proved to be equivalent to an empiric strategy for high risk patients.
引用
收藏
页码：271 / 276
页数：6
相关论文
共 50 条
  • [1] INVASIVE FUNGAL INFECTIONS IN HEMATOLOGIC MALIGNANCIES
    Djurasinovic, V.
    Tomin, D.
    Suvajdzic-Vukovic, N.
    Vidovic, A.
    Djunic, I.
    Virijevic, M.
    Colovic, N.
    Antic, D.
    Andjelic, B.
    Elezovic, I.
    Mihaljevic, B.
    HAEMATOLOGICA, 2012, 97 : 571 - 572
  • [2] Relevance of liposomal amphotericin B in the treatment of invasive fungal infections in patients with hematologic malignancies
    Garcia-Vidal, Carolina
    Vazquez, Lourdes
    Jarque, Isidro
    REVISTA IBEROAMERICANA DE MICOLOGIA, 2021, 38 (02): : 61 - 67
  • [3] Posaconazole serum levels and invasive fungal infections in patients with hematologic malignancies
    Hoenigl, M.
    Salzer, H. J.
    Raggam, R.
    Valentin, T.
    Rohn, A.
    Seeber, K.
    Strohmaier, A.
    Woelfler, A.
    Zollner-Schwetz, I.
    Linkesch, W.
    Krause, R.
    MYCOSES, 2011, 54 : 180 - 180
  • [4] Epidemiology of invasive fungal infections and antifungal therapy in patients with hematologic malignancies
    Hoenigl, Martin
    Zollner-Schwetz, Ines
    Sill, Heinz
    Lass-Floerl, Cornelia
    Krause, Robert
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 (15-16) : A47 - A47
  • [5] Treatment of invasive fungal infections in patients with hematologic malignancy
    Sanz, MA
    Salavert, M
    Jarque, I
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2002, : 4 - 12
  • [6] DIAGNOSIS AND TREATMENT OF FUNGAL-INFECTIONS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
    RADAELLI, F
    CORTELEZZI, A
    ZOCCHI, L
    CASTAGNONE, D
    BALDINI, L
    COLOMBI, M
    MOZZANA, R
    HEMATOLOGICAL ONCOLOGY, 1986, 4 (02) : 129 - 134
  • [7] Diagnostic Strategies for Invasive Fungal Infections in Patients With Hematologic Malignancies and Hematopoietic Stem Cell Transplant Recipients
    Norkin, Maxim
    Wingard, John R.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (08): : 941 - 949
  • [8] Invasive fungal infections in hematologic patients
    Lopez, F
    Jarque, I
    Martin, G
    Sanz, GF
    Palau, J
    Martinez, J
    de la Rubia, J
    Larrea, L
    Arnao, M
    Solves, P
    Cervera, J
    Martinez, ML
    Peman, J
    Gobernado, M
    Sanz, MA
    MEDICINA CLINICA, 1998, 110 (11): : 401 - 405
  • [9] Efficacy and safety of echinocandins for the prevention of invasive fungal infections in patients with hematologic malignancies
    Lee, Mei-Chuan
    Toh, Han-Siong
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S257 - S257
  • [10] FUNGAL-INFECTIONS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
    VENDITTI, M
    MARTINO, P
    SERRA, P
    MICROBIOLOGICAL, CHEMOTHERAPEUTICAL AND IMMUNOLOGICAL PROBLEMS IN HIGH RISK PATIENTS, 1989, 61 : 181 - 187
12345